# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001714899-25-000170
Filing Date
2025-08-11
Accepted
2025-08-11 16:25:48
Documents
66
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | dnli-20250630.htm iXBRL | 10-Q | 1444925
2 | EX-31.1 | exhibit311q22025.htm | EX-31.1 | 9895
3 | EX-31.2 | exhibit312q22025.htm | EX-31.2 | 9915
4 | EX-32.1 | exhibit321q22025.htm | EX-32.1 | 5553
5 | EX-32.2 | exhibit322q22025.htm | EX-32.2 | 5682
| Complete submission text file | 0001714899-25-000170.txt |  | 6388018

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | dnli-20250630.xsd | EX-101.SCH | 42995
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | dnli-20250630_cal.xml | EX-101.CAL | 63661
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | dnli-20250630_def.xml | EX-101.DEF | 169967
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | dnli-20250630_lab.xml | EX-101.LAB | 573301
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | dnli-20250630_pre.xml | EX-101.PRE | 386111
69 | EXTRACTED XBRL INSTANCE DOCUMENT | dnli-20250630_htm.xml | XML | 813267

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8547
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38311 | Film No.: 251202378
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)